vs
自然阳光（NATR）与Ribbon Communications Inc.（RBBN）财务数据对比。点击上方公司名可切换其他公司
Ribbon Communications Inc.的季度营收约是自然阳光的1.3倍（$162.6M vs $123.8M），Ribbon Communications Inc.净利率更高（54.8% vs 3.3%，领先51.5%），自然阳光同比增速更快（4.7% vs -10.3%），过去两年自然阳光的营收复合增速更高（5.6% vs -8.1%）
自然阳光产品公司（简称NSP）主营膳食补充剂与个人护理产品的生产制造，产品涵盖草本补充剂、维生素、矿物质制剂等品类。公司总部设于犹他州利希，生产工厂位于犹他州西班牙福克，是该领域知名的健康产品生产商。
睿宾通信公司（Ribbon Communications Inc.）主要为电信运营商、企业及关键基础设施领域提供软件、IP与光网络解决方案。公司于2017年由Genband与Sonus Networks合并成立，总部位于美国得克萨斯州普莱诺，是一家上市科技企业。
NATR vs RBBN — 直观对比
营收规模更大
RBBN
是对方的1.3倍
$123.8M
营收增速更快
NATR
高出15.0%
-10.3%
净利率更高
RBBN
高出51.5%
3.3%
两年增速更快
NATR
近两年复合增速
-8.1%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $123.8M | $162.6M |
| 净利润 | $4.1M | $89.1M |
| 毛利率 | 72.5% | 42.9% |
| 营业利润率 | 4.3% | 37.6% |
| 净利率 | 3.3% | 54.8% |
| 营收同比 | 4.7% | -10.3% |
| 净利润同比 | 1379.4% | — |
| 每股收益（稀释后） | $0.23 | $0.50 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NATRRBBN
| Q1 26 | — | $162.6M | ||
| Q4 25 | $123.8M | $227.3M | ||
| Q3 25 | $128.3M | $215.4M | ||
| Q2 25 | $114.8M | $220.6M | ||
| Q1 25 | $113.2M | $181.3M | ||
| Q4 24 | $118.2M | $251.4M | ||
| Q3 24 | $114.6M | $210.2M | ||
| Q2 24 | $110.6M | $192.6M |
净利润NATRRBBN
| Q1 26 | — | $89.1M | ||
| Q4 25 | $4.1M | — | ||
| Q3 25 | $5.3M | $-12.1M | ||
| Q2 25 | $5.3M | $-11.1M | ||
| Q1 25 | $4.7M | $-26.2M | ||
| Q4 24 | $-321.0K | — | ||
| Q3 24 | $4.3M | $-13.4M | ||
| Q2 24 | $1.3M | $-16.8M |
毛利率NATRRBBN
| Q1 26 | — | 42.9% | ||
| Q4 25 | 72.5% | 53.3% | ||
| Q3 25 | 73.3% | 50.1% | ||
| Q2 25 | 71.7% | 49.6% | ||
| Q1 25 | 72.1% | 45.4% | ||
| Q4 24 | 72.0% | 55.7% | ||
| Q3 24 | 71.3% | 52.1% | ||
| Q2 24 | 71.4% | 50.8% |
营业利润率NATRRBBN
| Q1 26 | — | 37.6% | ||
| Q4 25 | 4.3% | 4.1% | ||
| Q3 25 | 7.0% | 1.3% | ||
| Q2 25 | 3.7% | 1.9% | ||
| Q1 25 | 5.4% | -10.8% | ||
| Q4 24 | 3.8% | 13.2% | ||
| Q3 24 | 4.6% | -0.4% | ||
| Q2 24 | 5.1% | -1.0% |
净利率NATRRBBN
| Q1 26 | — | 54.8% | ||
| Q4 25 | 3.3% | — | ||
| Q3 25 | 4.2% | -5.6% | ||
| Q2 25 | 4.6% | -5.0% | ||
| Q1 25 | 4.2% | -14.5% | ||
| Q4 24 | -0.3% | — | ||
| Q3 24 | 3.8% | -6.4% | ||
| Q2 24 | 1.2% | -8.7% |
每股收益（稀释后）NATRRBBN
| Q1 26 | — | $0.50 | ||
| Q4 25 | $0.23 | $0.50 | ||
| Q3 25 | $0.30 | $-0.07 | ||
| Q2 25 | $0.28 | $-0.06 | ||
| Q1 25 | $0.25 | $-0.15 | ||
| Q4 24 | $-0.02 | $0.05 | ||
| Q3 24 | $0.23 | $-0.08 | ||
| Q2 24 | $0.07 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $93.9M | $67.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $161.6M | $419.1M |
| 总资产 | $261.1M | — |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NATRRBBN
| Q1 26 | — | $67.6M | ||
| Q4 25 | $93.9M | $96.4M | ||
| Q3 25 | $95.6M | $74.8M | ||
| Q2 25 | $81.3M | $60.5M | ||
| Q1 25 | $86.5M | $71.2M | ||
| Q4 24 | $84.7M | $87.8M | ||
| Q3 24 | $78.7M | $37.2M | ||
| Q2 24 | $68.7M | $64.6M |
总债务NATRRBBN
| Q1 26 | — | — | ||
| Q4 25 | — | $342.1M | ||
| Q3 25 | — | $344.3M | ||
| Q2 25 | — | $346.5M | ||
| Q1 25 | — | $347.4M | ||
| Q4 24 | — | $348.3M | ||
| Q3 24 | — | $349.1M | ||
| Q2 24 | — | $350.0M |
股东权益NATRRBBN
| Q1 26 | — | $419.1M | ||
| Q4 25 | $161.6M | $449.0M | ||
| Q3 25 | $166.7M | $360.1M | ||
| Q2 25 | $163.7M | $370.4M | ||
| Q1 25 | $167.1M | $381.8M | ||
| Q4 24 | $161.0M | $404.6M | ||
| Q3 24 | $162.6M | $395.5M | ||
| Q2 24 | $156.4M | $405.0M |
总资产NATRRBBN
| Q1 26 | — | — | ||
| Q4 25 | $261.1M | $1.2B | ||
| Q3 25 | $264.8M | $1.1B | ||
| Q2 25 | $254.9M | $1.1B | ||
| Q1 25 | $252.7M | $1.1B | ||
| Q4 24 | $240.9M | $1.2B | ||
| Q3 24 | $245.3M | $1.1B | ||
| Q2 24 | $235.8M | $1.1B |
负债/权益比NATRRBBN
| Q1 26 | — | — | ||
| Q4 25 | — | 0.76× | ||
| Q3 25 | — | 0.96× | ||
| Q2 25 | — | 0.94× | ||
| Q1 25 | — | 0.91× | ||
| Q4 24 | — | 0.86× | ||
| Q3 24 | — | 0.88× | ||
| Q2 24 | — | 0.86× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $9.9M | — |
| 自由现金流经营现金流 - 资本支出 | $7.6M | — |
| 自由现金流率自由现金流/营收 | 6.1% | — |
| 资本支出强度资本支出/营收 | 1.9% | — |
| 现金转化率经营现金流/净利润 | 2.41× | — |
| 过去12个月自由现金流最近4个季度 | $28.8M | — |
8季度趋势，按日历期对齐
经营现金流NATRRBBN
| Q1 26 | — | — | ||
| Q4 25 | $9.9M | $29.2M | ||
| Q3 25 | $18.5M | $26.5M | ||
| Q2 25 | $4.3M | $-795.0K | ||
| Q1 25 | $2.6M | $-3.5M | ||
| Q4 24 | $12.2M | $61.8M | ||
| Q3 24 | $9.6M | $-14.8M | ||
| Q2 24 | $1.3M | $-9.8M |
自由现金流NATRRBBN
| Q1 26 | — | — | ||
| Q4 25 | $7.6M | $27.3M | ||
| Q3 25 | $16.8M | $21.0M | ||
| Q2 25 | $3.0M | $-6.5M | ||
| Q1 25 | $1.5M | $-15.7M | ||
| Q4 24 | $10.0M | $53.8M | ||
| Q3 24 | $7.9M | $-23.7M | ||
| Q2 24 | $-2.0M | $-12.9M |
自由现金流率NATRRBBN
| Q1 26 | — | — | ||
| Q4 25 | 6.1% | 12.0% | ||
| Q3 25 | 13.1% | 9.7% | ||
| Q2 25 | 2.6% | -2.9% | ||
| Q1 25 | 1.3% | -8.7% | ||
| Q4 24 | 8.5% | 21.4% | ||
| Q3 24 | 6.9% | -11.3% | ||
| Q2 24 | -1.9% | -6.7% |
资本支出强度NATRRBBN
| Q1 26 | — | — | ||
| Q4 25 | 1.9% | 0.9% | ||
| Q3 25 | 1.3% | 2.6% | ||
| Q2 25 | 1.2% | 2.6% | ||
| Q1 25 | 1.0% | 6.7% | ||
| Q4 24 | 1.9% | 3.2% | ||
| Q3 24 | 1.5% | 4.2% | ||
| Q2 24 | 3.0% | 1.6% |
现金转化率NATRRBBN
| Q1 26 | — | — | ||
| Q4 25 | 2.41× | — | ||
| Q3 25 | 3.46× | — | ||
| Q2 25 | 0.81× | — | ||
| Q1 25 | 0.55× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.21× | — | ||
| Q2 24 | 0.97× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
RBBN
| Service | $94.5M | 58% |
| Product | $68.1M | 42% |
